Application 220493
- Type
- ANDA
- Sponsor
- ANTHEA PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.25% | No | No |
| 002 | BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.5% | No | No |
| 003 | BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.75% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220493-001 | BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2026-04-22 | |
| A220493-002 | BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2026-04-22 | |
| A220493-003 | BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | 0.75% | INJECTABLE / INJECTION | AP | 2026-04-22 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A220493-001 | AP |
| A220493-002 | AP |
| A220493-003 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A220493-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2026-04-22 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A220493-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2026-04-22 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A220493-003 | BUPIVACAINE HYDROCHLORIDE | 0.75% | INJECTABLE / INJECTION | AP | 2026-04-22 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A220493-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2026-04-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A220493-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2026-04-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A220493-003 | BUPIVACAINE HYDROCHLORIDE | 0.75% | INJECTABLE / INJECTION | AP | 2026-04-22 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A220493-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2026-04-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A220493-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2026-04-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A220493-003 | BUPIVACAINE HYDROCHLORIDE | 0.75% | INJECTABLE / INJECTION | AP | 2026-04-22 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220493-001 | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | 2026-04-22 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220493-002 | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | 2026-04-22 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220493-003 | BUPIVACAINE HYDROCHLORIDE | 0.75% | INJECTABLE / INJECTION | AP | 2026-04-22 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A220493-001 | AP | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A220493-002 | AP | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A220493-003 | AP | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A220493-001 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A220493-002 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A220493-003 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A220493-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A220493-002 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A220493-003 | AP | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220493-001 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220493-002 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220493-003 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Fosun Pharma USA Inc. | 3a996abe-0bb9-4590-e063-6394a90a0b60 | 2025-07-23 | Boxed warning, Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Eugia US LLC | ffecf450-1f01-4721-8e10-251385852612 | 2025-05-29 | Boxed warning, Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Huons Co., Ltd. | 2dc693df-3218-4a90-b3f7-21e80966a851 | 2024-11-20 | Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
| SENSORCAINE MPF | BUPIVACAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | b6bfc04a-1868-4630-9ca1-8c027af97ce3 | 2024-11-18 | Boxed warning, Warnings, Adverse reactions | BUPIVACAINE HYDROCHLORIDE |
| SENSORCAINE MPF | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Fresenius Kabi USA, LLC | eb6d8fee-def4-4c96-9972-695e8cea8ea8 | 2024-10-15 | Boxed warning, Warnings, Adverse reactions | BUPIVACAINE HYDROCHLORIDE |
| BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 950d82b6-76a1-0c08-e053-2a95a90a3a92 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine hydrochloride | BUPIVACAINE HYDROCHLORIDE | Somerset Therapeutics, LLC | bcaab86f-20f0-4482-8d73-e29b36dced58 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | Bupivacaine hydrochloride BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | A-S Medication Solutions | 1091d4d8-5dad-46e1-8f26-7bc0c5dd833f | 2024-05-31 | Boxed warning, Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 8815c8c6-eed8-4afe-a5c1-44d2194025a3 | 2024-04-11 | Boxed warning, Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 4595c642-1869-436c-9550-8f9f255efd27 | 2024-04-11 | Boxed warning, Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Asclemed USA, Inc. | f37a19ad-5e69-44a8-947b-847df2106fb3 | 2023-08-10 | Boxed warning, Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Asclemed USA, Inc. | 8759cac8-d977-4c2a-814c-5b59f2f0c910 | 2023-08-09 | Boxed warning, Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
| Marvona SUIK | BUPIVACAINE HYDROCHLORIDE | Asclemed USA, Inc. | f03f28d9-e42e-404d-9c9c-7707aedb478c | 2023-07-19 | Boxed warning, Warnings, Adverse reactions | BUPIVACAINE HYDROCHLORIDE |
| bupivacaine hydrochloride | BUPIVACAINE HYDROCHLORIDE | Meitheal Pharmaceuticals Inc | fe340f98-a0f3-446e-b281-47fd91c1e537 | 2023-06-23 | Boxed warning, Warnings, Adverse reactions | bupivacaine hydrochloride BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine HCl | BUPIVACAINE HYDROCHLORIDE | Xellia Pharmaceuticals USA LLC | 3335dabe-66d5-440b-a59a-b62993030e0f | 2023-06-09 | Warnings, Adverse reactions | BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine HCl | BUPIVACAINE HYDROCHLORIDE | Xellia Pharmaceuticals USA LLC | f29c905e-9a55-446f-a89d-860ad9ade7ad | 2023-06-09 | Boxed warning, Warnings, Adverse reactions | BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 694926ac-aff0-aa1f-e053-2991aa0a9588 | 2023-05-22 | Boxed warning, Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
| Sensorcaine MPF | BUPIVACAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | e700eb7b-8b14-49c9-96b2-331f18776e45 | 2023-05-12 | Boxed warning, Warnings, Adverse reactions | BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | ada6a9bf-f7cb-035a-e053-2a95a90a6a3d | 2023-05-03 | Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | d1642239-4230-b679-e053-2a95a90a3b7c | 2023-05-02 | Boxed warning, Warnings, Adverse reactions | Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.